Mammalian Granulocyte–Macrophage Colony-stimulating Factor Receptor Expressed in Primary Avian Hematopoietic Progenitors: Lineage-specific Regulation of Proliferation and Differentiation by Wessely, Oliver et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/98/05/1041/11 $2.00
The Journal of Cell Biology, Volume 141, Number 4, May 18, 1998 1041–1051
http://www.jcb.org 1041
 
Mammalian Granulocyte–Macrophage Colony-stimulating
Factor Receptor Expressed in Primary Avian
Hematopoietic Progenitors: Lineage-specific
Regulation of Proliferation and Differentiation
 
Oliver Wessely, Eva-Maria Deiner, Kim Chew Lim, Georg Mellitzer, Peter Steinlein,
and Hartmut Beug
 
Institute for Molecular Pathology, A-1030 Vienna, Austria
 
Abstract. 
 
The cytokine Granulocyte–Macrophage Col-
ony-Stimulating Factor (GM-CSF) regulates prolifera-
tion, differentiation, and apoptosis during myelopoiesis 
and erythropoiesis. Structure–function relationships of 
GM-CSF interactions with its receptor (GM-R), the 
biochemistry of GM-R signal transduction, and GM-
CSF action in vivo are relatively well understood. Much 
less is known, however, about GM-R function in pri-
mary hematopoietic cells. In this paper we show that 
expression of the human GM-R in a heterologous cell 
system (primary avian erythroid and myeloid cells) 
confirms respective results in murine or human cell 
lines, but also provides new insights how the GM-R 
regulates progenitor proliferation and differentiation. 
As expected, the hGM-CSF stimulated myeloid pro-
genitor proliferation and differentiation and enhanced 
erythroid progenitor proliferation during terminal dif-
ferentiation. In the latter cells, however, the hGM-R 
only partially substituted for the activities of the eryth-
ropoietin receptor (EpoR). It failed to replace the 
EpoR in its cooperation with c-Kit to induce long-term 
proliferation of erythroid progenitors. Furthermore, 
the hGM-R 
 
a
 
 chain specifically interfered with EpoR 
signaling, an activity neither seen for the 
 
b
 
c
 
 subunit of 
the receptor complex alone, nor for the 
 
a
 
 chain of the 
closely related Interleukin-3 receptor. These results 
point to a novel role of the GM-R 
 
a
 
 chain in defining 
cell type–specific functions of the GM-R.
 
T
 
he
 
 tight regulation of proliferation, differentiation,
and apoptosis required for homeostasis during he-
matopoiesis is to a large extent effected by numer-
ous humoral factors (cytokines). These polypeptide fac-
tors induce and maintain the production of the correct
amounts of immature and mature hematopoietic cells.
Furthermore, cytokines are responsible for the fast re-
sponses of the hematopoietic system to specific needs aris-
ing from immune responses, blood loss, or during disease.
One of the best-studied cytokines is the Granulocyte–
Macrophage Colony-Stimulating Factor (GM-CSF).
 
1
 
 It
represents a major regulator at different stages of hemato-
poiesis (Metcalf, 1980). GM-CSF induces a large variety of
biological effects, such as proliferation induction in early
progenitors, stimulation of differentiation along various
myeloid lineages depending on factor concentration (Met-
calf, 1989), cooperation with or even replacement of eryth-
roid cytokines (Nishijima et al., 1995), as well as regulation
of mature cell function (Metcalf, 1980). Finally, GM-CSF
also stimulates the proliferation of multipotent CD34-pos-
itive progenitors (Sonoda et al., 1994).
GM-CSF binds to a heterodimeric receptor complex
(GM-R)
 
 
 
consisting of an 
 
a
 
 chain (GM-R
 
a
 
) and a common
 
b
 
 chain (
 
b
 
c
 
). Whereas the 
 
a
 
 chain confers specific binding
to GM-CSF, 
 
b
 
c
 
 by itself does not bind the ligand, but alters
the affinity of the receptor complex for GM-CSF from low
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1. 
 
Abbreviations used in this paper
 
: AS, anemic serum; 
 
b
 
c
 
, common 
 
b
 
chain; BPA, burst-promoting activity; cMGF, chicken myelomonocytic
growth factor; Epo, erythropoietin; EpoR, erythropoietin receptor; GM-
CSF, Granulocyte–Macrophage Colony-Stimulating Factor; GM-R, GM-
CSF receptor; GM-R
 
a
 
, GM-R 
 
a
 
 chain; IL, interleukin; IRES, internal ri-
bosome entry site; ts, temperature sensitive.
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to high affinity. Furthermore, 
 
b
 
c
 
 associates with the intra-
cellular tyrosine kinase Jak2 (Quelle et al., 1994). Since
neither the GM-R
 
a
 
, nor 
 
b
 
c
 
 have an intrinsic kinase activ-
ity, this association is thought to be a necessary step in trig-
gering signal transduction. Interfering with the association
between 
 
b
 
c
 
 and Jak2 renders respective GM-R mutant
proteins unable to confer a mitogenic signal (Watanabe et
al., 1996). After ligand activation of the GM-R Jak2 phos-
phorylates several tyrosine residues on 
 
b
 
c
 
. These subse-
quently interact with the src homology region 2 (SH-2) do-
mains of signaling intermediates like Stat5 (Ihle et al., 1994;
Mui et al., 1995; Wakao et al., 1995), as well as phosphati-
dylinositol-3-kinase (PI-3-kinase), Grb2, Shc, and PTP-1D
(Lanfrancone et al., 1995; Rao and Mufson, 1995; Pratt et
al., 1996).
In contrast to 
 
b
 
c
 
, the GM-R 
 
a
 
 chain has a very small cy-
toplasmic domain that lacks tyrosine residues phosphory-
lated by Jak-2 or other kinases. Nevertheless, the 
 
a
 
 chain
contributes to the activity of the GM-R, since a receptor
complex with an 
 
a
 
 chain lacking its cytoplasmic tail is un-
able to promote proliferation and differentiation (Saka-
maki et al., 1992; Weiss et al., 1993; Matsuguchi et al.,
1997). How the 
 
a 
 
chain contributes to receptor function is
still obscure, but obviously important to understand recep-
tor-specific signal transduction.
The 
 
b
 
c
 
 receptor subunit is not only used by the GM-R,
but also by the interleukin (IL)-3 and IL-5 receptors. Like
the GM-R, both of these receptors have a receptor-spe-
cific 
 
a
 
 chain, but they also require interaction with 
 
b
 
c
 
 for
signal transduction and biological activity. Despite this
shared use of 
 
b
 
c
 
, all three receptor complexes have distinct
biological activities when activated by their respective
ligands. IL-5 induces differentiation of eosinophils (Dent
et al., 1990), a specificity explained mainly by the restricted
expression pattern of the IL-5 receptor 
 
a
 
 chain. In con-
trast, IL-3 functions on a similar subset of hematopoietic
progenitors as GM-CSF. However, its activity is much less
biased to myeloid progenitors as the activity of GM-CSF
(Nimer and Uchida, 1995). Thus, receptor specificity may
be dependent on signaling events mediated by the 
 
a
 
 chains
of the receptors.
In contrast to this rather detailed knowledge on recep-
tor structure and in vivo function, much less is known
about how ligand activation of the GM-R affects cell pro-
liferation, differentiation, and apoptosis in primary, differ-
entiating hematopoietic progenitors. So far, mainly im-
mortalized cell lines of human or murine origin were used
in such studies (Spooncer et al., 1986; Jubinsky et al., 1993;
Mui et al., 1995). However, many of these lines are altered
in their response to cytokines and sometimes exhibit in-
complete and/or aberrant differentiation (for review see
Beug et al., 1995).
Clones of chicken erythroid and myelomonocytic pro-
genitors capable of sustained proliferation offer an alter-
native. Long-term proliferation can be induced by trans-
formation with temperature-sensitive (ts) oncoproteins
(ts-v-sea, ts-gag-myb-ets; Beug
 
 
 
et al
 
.
 
, 1984; Knight
 
 
 
et al
 
.
 
,
1988) or—in the case of erythroid progenitors—by combi-
nations of “self renewal factors,” i.e., receptor tyrosine ki-
nase ligands plus steroid hormones (Hayman et al., 1993;
Beug et al., 1995). In both cases, the proliferating progeni-
tors can be induced to terminal differentiation into eryth-
rocytes or macrophages either by ts oncoprotein inactiva-
tion at 42
 
8
 
C or by replacement of “self-renewal factors” by
cytokines required for differentiation.
In this paper, we sought to clarify the action of the GM-R
and the cooperation between its 
 
a 
 
and 
 
b
 
 chains by ex-
pressing these proteins in the above-described heterolo-
gous cell systems. Since avian hematopoietic progenitors are
unresponsive to mammalian GM-CSF or other cytokines,
e.g., those present in serum (Steinlein et al., 1994; Wessely
et al., 1997
 
b
 
; Beug, H., and E.M. Deiner, unpublished ob-
servations), this allowed to test for the specific contribu-
tions of the GM-R. The usefulness of such an approach to
analyze mammalian hematopoietic regulators and onco-
proteins has recently been demonstrated (Tran Quang
et al., 1997). Here, we show that GM-CSF promotes differ-
entiation of hGM-R–expressing myelomonocytic progeni-
tors and cooperates with the EpoR in regulating erythroid
differentiation. Interestingly, however, non-liganded exog-
enous hGM-R renders erythroid progenitors
 
 
 
unresponsive
to signaling via the endogenous aEpoR. This quenching of
Epo-responsiveness is specifically caused by the hGM-R 
 
a
 
chain, while neither 
 
b
 
c
 
 nor the hIL-3 receptor 
 
a
 
 chain in-
duce this effect. Epo responsiveness of the GM-R–expressing
cells can be restored by an exogenously expressed mEpoR.
However, the hGM-R cannot substitute for all functions of
the mEpoR, in particular it failed to cooperate with c-Kit
to induce long-term proliferation in erythroblasts.
These results constitute the first demonstration that the
 
a
 
 chain of the GM-R may contribute to lineage commit-
ment by differential signal transduction in erythroid and
myeloid hematopoietic cell types.
 
Materials and Methods
 
Viruses and Cells
 
The cDNAs encoding the hGM-R
 
a
 
 was a gift of Genentech Inc. (South
San Francisco, CA), the hIL3-R
 
a
 
 and 
 
b
 
c
 
 were generously provided by
DNAX (Palo Alto, CA). The construction of the pCRNCM/hGM-R ret-
roviral vector will be described in detail elsewhere. In general, the strategy
used was similar to that described in Tran Quang et al. (1997), namely sep-
arating the two cDNAs for GM-R
 
a
 
 and 
 
b
 
c
 
 by an internal ribosome entry
site (IRES; Elroy-Stein et al
 
.
 
, 1989). Additionally, to express the single
chains of the receptor complex, 
 
b
 
c
 
 was cloned into the avian retroviral ex-
pression vector pOli (Wessely et al., 1997
 
b
 
) and the hGM-R
 
a
 
, as well as
the hIL3-R
 
a
 
, were inserted behind the cytomegalovirus (CMV) promoter
of pCRNCM (Steinlein et al., 1994). RCAS/EpoR was a kind gift of J.
Ghysdael (Institute Curie, Orsay, France).
Chicken embryo fibroblasts expressing the retroviral constructs
pCRNCM/hGM-R, pCRNCM/hGM-R
 
a
 
, pCRNCM/hIL3-R
 
a
 
 and pOli/
 
b
 
c
 
were generated as described earlier (Zenke et al., 1990; Wessely et al.,
1997
 
b
 
). All fibroblasts were grown in standard growth medium (Graf,
1973). Ts21-E26 transformed myeloblasts, SCF progenitors, and SCF/
TGF
 
a
 
 progenitors were grown from the bone marrow of 3–10-d-old
Spafas chicks as described previously (Hayman et al., 1993; Schroeder et al.,
1993; Woldmann et al., 1997). The HD3 erythroblast cell line HD3-EpoR-
E22 has been described previously (Mellitzer et al., 1996). Steroids (estra-
diol, dexamethasone) were used at a final concentration of 10
 
2
 
6
 
 M, cMGF
at 10 ng/ml, aSCF at 100 ng/ml (Bartunek et al., 1996), TGF
 
a
 
 (Promega,
Heidelberg, Germany) at 5 ng/ml, IGF-1 (Sigma Chemical Co., St. Louis,
MO) at 40 ng/ml, hGM-CSF (Promega) at 10 ng/ml, hEpo at 10 U/ml, in-
sulin at 1.4 nM, and PD 153035 at 2.5 
 
m
 
M (Fry et al., 1994).
 
Infection of Primary Erythroblasts and Myeloblasts 
with Retroviruses
 
To infect erythroblasts, freshly prepared chicken bone marrow cells were 
Wessely et al. 
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cocultivated with mitomycin C–treated CEF expressing the respective ret-
roviral constructs for 2 d (Fuerstenberg et al., 1992). The cells were then
either further propagated as a mass culture or seeded in CFU-E-methocel
containing aSCF, TGF
 
a
 
, E2, and Dex. Outgrowing colonies were isolated
and expanded in CFU-E medium plus aSCF, TGF
 
a
 
, E2, and Dex (Hay-
man et al., 1993) Myeloid progenitors were obtained by coculturing bone
marrow cells with both mitomycin C–treated, ts21-E26–transformed my-
eloblasts and CEF expressing the respective retroviral constructs. Subse-
quently, the myeloid progenitors were maintained in the presence of
cMGF (Beug et al., 1984).
 
Proliferation Kinetics
 
To determine the growth kinetics of erythroblast mass cultures, cells were
subjected to daily partial medium changes plus re-addition of fresh fac-
tors. They were kept at densities of 2–4 
 
3 
 
10
 
6 
 
cells/ml, and aliquots
counted in an electronic cell counter (CASY-1, Schärfe-System, Reutlingen,
FRG). Cumulative cell numbers were determined as described in Fuersten-
berg et al. (1992).
 
Differentiation of Myeloid Progenitors
 
Cells were washed twice in PBS and seeded at 1–2 
 
3 
 
10
 
6
 
 cells/ml into 35-mm
dishes containing 2 ml of differentiation medium (Woldmann et al., 1997)
and were incubated at 42
 
8
 
C. When indicated, cMGF or hGM-CSF was
added. The cells were maintained at densities of 2–4 
 
3 
 
10
 
6
 
 cells/ml,
counted daily, and aliquots were removed at days 3–5 for morphological
analysis by cytocentrifugation onto slides and staining with histological
dyes (Beug et al., 1984).
 
Differentiation of Erythroid Progenitors
 
Cells were washed twice in PBS and seeded at 1–2 
 
3 
 
10
 
6
 
 cells/ml into
35-mm dishes containing 2 ml of differentiation medium (Dolznig et al.,
1995). When indicated, 3–5% high titer anemic serum (as a source for
aEpo), insulin, hGM-CSF, and/or hEpo were added. Cells were counted
daily and maintained at densities of 2–4 
 
3 
 
10
 
6
 
 cells/ml. Aliquots were re-
moved for hemoglobin determination and morphological analysis at the
days indicated.
 
Analysis of Differentiation by Cell Morphology
and Staining
 
Cells were cytocentrifuged onto slides and subsequently stained with his-
tological dyes and neutral benzidine for hemoglobin as described in (Beug
et al., 1982). Images were taken using a CCD camera (Photometric, Tuc-
son, AZ) and a blue filter (480 nm), so that mature cells (stained yellow to
brownish) appear darkly stained. Images were processed with Photoshop
(Adobe Systems Inc., Mountain View, CA).
 
Photometric Hemoglobin Assay
 
Three 50-
 
m
 
l aliquots of the cultures were removed and processed for pho-
tometric determination of hemoglobin as described (Kowenz et al., 1987).
Values obtained were normalized to cell number.
 
Northern Blot Analysis
 
Cells were lysed in GITC buffer (Chomczynski and Sacchi, 1987) and
NaAc, pH 4.0, was added to 25 mM. The solution was extracted with H
 
2
 
O-
saturated phenol, chloroform, and isoamylalcohol. After precipitation
with isopropanol, the pellet was dissolved in 10 mM Tris/HCl, pH 7.0, 1 mM
EDTA, 0.2% SDS, and proteinaseK was added to 200 
 
m
 
g/ml. After a 30-
min incubation at 37
 
8
 
C, the solution was extracted with phenol/chloro-
form/isoamylalcohol (25:24:1), pH 7.0, and then precipitated with ethanol.
10–20 
 
m
 
g of RNA was run on a formaldehyde-containing agarose gel and
transferred to nylon filters (Gene Screen, Dupont NEN, Boston, MA)
using conventional procedures. Single-stranded DNA probes were radio-
actively labeled with 
 
32
 
P by using an Oligolabeling Kit (Pharmacia Bio-
technology Inc., Piscataway, NJ) and hybridized at 65
 
8
 
C in 7% SDS, 0.5 M
Na phosphate, pH 7.0, 1 mM EDTA. Membranes were washed in 1%
SDS, 40 mM Na phosphate at 65
 
8
 
C, and then autoradiographed.
 
Growth Factor Treatment and Cell Lysis
 
For growth factor stimulation primary myeloid and erythroid progenitors
were washed once with PBS and then withdrawn from factors by cultiva-
tion for 12 h in differentiation medium (Dolznig et al., 1995). Afterwards
the cells were washed twice with PBS, suspended in differentiation me-
dium, and then treated as indicated with either 50 ng/ml TGF
 
a
 
, 50 U/ml
hEpo, 100 ng/ml hGM-CSF, 100 ng/ml cMGF, or without factors for 15
min at 37
 
8
 
C. Stimulation of HD3-EpoR-E22 cells was performed similarly
except that the cells were withdrawn from growth factors using serum-free
differentiation medium using 2.5 
 
m
 
M PD153035 to inhibit v-ErbB activity
(Mellitzer et al., 1996) and were shifted to 42
 
8
 
 instead of 37
 
8
 
C.
After stimulation, 10
 
6
 
 cells were lysed in 10 
 
m
 
l EMSA lysis buffer (20 mM
Hepes, pH 7.9, 140 mM NaCl, 1.5 mM MgCl
 
2
 
, 1.0% NP-40, 1 mM sodium
orthovanadate, 10 
 
m
 
g/ml aprotinin, and 2 
 
m
 
g/ml leupeptin), or in 20 
 
m
 
l
immunoprecipitation buffer (1% Triton-X-100, 50 mM Tris/HCl, pH 8.0,
100 mM NaCl, 1 mM sodium orthovanadate, 10 
 
m
 
g/ml aprotinin, and 2
 
m
 
g/ml leupeptin), respectively. Cell lysates were cleared by centrifugation
for 15 min at 15,000 rpm before use.
 
Mobility Shift (EMSA) Assay
 
This assay was performed as described earlier (Mellitzer et al., 1996) using
the IFP53-GUS oligonucleotide to detect complex formation with Stat5b.
 
Phosphotyrosine Blot
 
Lysates from growth factor–stimulated cells were subjected to Western
blot analysis as described earlier (Hayman et al., 1993; Mellitzer et al.,
1996). Samples were run on an 8% SDS-PAGE gel, transferred to nitro-
cellulose membranes (Dupont-NEN, Boston, MA), and then probed with
an anti-phosphotyrosine antibody (4G10; Upstate Biotechnology Inc.,
Lake Placid, NY).
 
Results
 
hGM-R Functionally Expressed in
ts21-E26–transformed Myeloid Progenitors
 
To demonstrate the functionality of the hGM-R in chicken
cells, we introduced it into myelomonocytic progenitors
transformed by the ts21 mutant of the E26 virus, express-
ing a thermolabile p135
 
gag-myb-ets
 
 oncoprotein. These ts21-
E26 myeloblasts proliferate at 37
 
8
 
C, if supplied with the
avian cytokine cMGF (Leutz et al., 1988, 1989). After in-
activation of the ts21-E26 oncoprotein at 428C, the cells
differentiate into macrophages, again requiring cMGF
(Beug et al., 1984; Woldmann et al., 1997).
Stable expression of both chains of the hGM-R was
achieved by constructing a retrovirus that coexpresses the
a and the bc chain (for a schematic drawing see Fig. 1 A).
Both chains were inserted behind an internal CMV pro-
moter, separated from each other by an IRES (Elroy-Stein
et al., 1989). Chicken embryo fibroblasts producing this vi-
rus were cocultivated with a mixture of ts21-E26–trans-
formed myeloblasts and freshly prepared chicken bone
marrow cells. Methocel colonies growing in the presence
of cMGF and G418 were expanded and analyzed for the
expression of the hGM-R by Northern analysis. Fig. 1 B
shows that these clones express mRNA for both the a and
the bc chain. Also, treatment with hGM-CSF caused only
in hGM-R–expressing clones the phosphorylation of a
specific 130-kD protein in phosphotyrosine blots, whereas
cMGF treatment caused phosphorylation of a slightly
smaller protein in both hGM-R expressing and control
ts21-E26 cells (Fig. 1 C). Finally, recombinant hGM-CSF
and cMGF evoked a similar, short-term proliferation re-
sponse in hGM-R expressing ts21 cells (Fig. 2 B; see be-
low). Control cells only responded to recombinant cMGF
(Fig. 2 A). This clearly shows that the exogenous hGM-R
is bioactive.The Journal of Cell Biology, Volume 141, 1998 1044
Next, we analyzed whether hGM-CSF could replace
cMGF in factor-dependent differentiation of ts21-E26
cells. Differentiation was analyzed by three parameters.
First, daily cell counting shows that ts21-E26 myeloblasts
differentiating at 428C undergo a few cell divisions before
becoming stationary after 2–3 d. Second, they become ad-
herent and acquire a typical macrophage morphology in
cytospin preparations stained with histological dyes. And
thirdly, they express typical macrophage antigens (MC22/3,
MC47/83) and lose myeloblast antigens (MC4M12/26;
Beug et al., 1984). When ts21-E26 cells expressing the
hGM-R were induced to differentiate at 428C, hGM-CSF
fully replaced cMGF. After initial transient proliferation
(Fig. 2 B; somewhat prolonged in case of hGM-CSF treat-
ment), hGM-R–expressing ts21-E26 cells differentiated
into macrophage-like cells in both hGM-CSF and cMGF
(Fig. 2 C, right panels). In contrast, control cells lacking
the hGM-R showed the expected differentiation behavior
in cMGF, but underwent apoptosis in hGM-CSF (Fig. 2 C,
left panels). Similar to the cMGF-treated control cells, the
hGM-R–expressing cells differentiating in the presence
of hGM-CSF gained expression of macrophage surface
markers detected by the monoclonal antibodies MC22-3
and MC47/83, while they lost the immature cell marker
MC4M12/26 (data not shown; Beug et al., 1984).
Taken together, these results indicate that the hGM-R
can be functionally expressed in avian myelomonocytic
progenitors, inducing typical differentiation accompanied
by transient proliferation.
Cooperation of the hGM-R with the EpoR during 
Erythroid Differentiation Requires hGM-CSF
In human or murine bone marrow, GM-CSF acts as a
burst-promoting activity (BPA), supporting Epo-depen-
dent erythroid differentiation (Metcalf, 1989). So far, we
have been unable to find a similar activity for cMGF
(Beug, H., and E.M. Deiner, unpublished observations).
Sequence comparisons suggested cMGF to be homolo-
gous to IL-6 or G-CSF rather than to GM-CSF (Boulay
and Paul, 1993). It was therefore of interest whether erythroid
progenitors expressing the hGM-R would respond to
hGM-CSF in a fashion analogous to early mammalian
erythroid progenitors (BFU-E). To isolate normal eryth-
roblast clones expressing the hGM-R, avian bone marrow
cells growing in aSCF, TGFa, estradiol, and dexametha-
sone (Wessely et al., 1997a) were infected with the hGM-R
retrovirus and seeded into methocel containing G418. Re-
sistant colonies were picked and expanded. After confirm-
ing expression of both hGM-R chains by Northern and
phosphotyrosine blot analysis (data not shown; see Fig. 1),
hGM-R–expressing clones as well as empty vector control
clones were induced to differentiate in insulin alone (con-
trol), hGM-CSF plus insulin, aEpo-containing anemic
chicken serum (AS) plus insulin, and in both AS and
hGM-CSF plus insulin. After 4 d, cells were subjected to
cytocentrifugation followed by histochemical staining for
hemoglobin. In addition, we quantitated hemoglobin (nor-
malized to cell number) in these cell populations (see Ma-
terials and Methods).
As expected, control cells lacking the hGM-R differenti-
ate in AS/insulin regardless of the presence or absence of
hGM-CSF (Fig. 3, A and B, left panels). In the absence of
AS (i.e., in insulin alone or hGM-CSF plus insulin) these
cells undergo abortive differentiation (production of aber-
rant, partially mature cells with reduced hemoglobin lev-
els, followed by apoptosis). This is evident both from
hemoglobin accumulation (Fig. 3 A, left) and cytospin
analysis (data not shown). The slight decrease in hemoglo-
bin content caused by hGM-CSF in the presence of AS is
most likely caused by endotoxin present in the hGM-CSF
preparation used, since it could be avoided by using purer
batches of hGM-CSF (data not shown).
Erythroblast clones expressing the hGM-R differenti-
ated in the presence of insulin plus both hGM-CSF and
AS, but showed abortive differentiation in hGM-CSF plus
insulin alone (Fig. 3, A and B, right panel). This confirmed,
that hGM-CSF cannot induce erythroid differentiation on
its own, rather exhibiting a BPA-like activity in hGM-
R–expressing chicken erythroblasts. Surprisingly however,
the hGM-R–expressing cells no longer differentiated in
the presence of AS plus insulin, showing only abortive dif-
ferentiation as with insulin alone. They expressed only
slightly elevated levels of hemoglobin (Fig. 3 A, right panel)
Figure 1. Expression of the hGM-R complex in ts21-E26 trans-
formed myeloblasts. (A) Schematic drawing of the avian retrovi-
ral vector constructed to express both hGM-Ra and bc. Besides
avian AEV-ES4 LTRs, the virus contains a neomycin resistance
gene fused to gag and an internal CMV promoter. The bc and
hGM-Ra cDNAs are separated by an IRES (Elroy-Stein et al.,
1989). (B) Northern blot analysis of myeloblast clones expressing
the hGM-R or infected with the control vector (ts21#C2 and
#D3). The blot was subsequently hybridized with both an a chain
and a bc-specific fragment. Blots from the GM-R–expressing and
control clones were exposed for 5 and 20 d, respectively. Equal
loading was verified by methylene blue staining of the blot before
hybridization. (C) ts21-E26 transformed myeloblast clones har-
boring an empty vector (#C2) or the hGM-R expression vector
(#G3) were withdrawn from factors overnight. They were then
stimulated for 15 min with hGM-CSF, cMGF, or left untreated.
Lysates were analyzed by phosphotyrosine blot as described in
Materials and Methods. Open circle, the 130-kD bc chain of the
GM-R phosphorylated in response to hGM-CSF; arrowheads, the
slightly smaller band phosphorylated in response to cMGF in
both cell types. Note that some putative substrate proteins (e.g.,
z75 kD) show enhanced phosphorylation upon treatment with
hGM-CSF and cMGF.Wessely et al. GM-R in Avian Hematopoiesis 1045
and appeared as either dead cells or partially mature cells
expressing little or no hemoglobin in cytospins (Fig. 3 B,
right panels).
These results show that the ligand-activated hGM-R
supports AS-dependent erythroid differentiation and dis-
plays a BPA-like activity on erythroid progenitors. How-
ever, expression of the non-liganded receptor seems to in-
terfere with erythroid differentiation, preventing a normal
response to differentiation factors like aEpo.
The a Chain of the hGM-R Is Sufficient to Interfere 
with Erythroid Differentiation
The a chain of the GM-R is mainly responsible for ligand
binding, whereas the b chain is necessary for interaction
with JAK2 and other signal transduction intermediates
(Quelle et al., 1994; Watanabe et al., 1996). Thus we sought
to determine, whether the interference with AS-induced
differentiation caused by the complete hGM-R receptor
Figure 2. GM-CSF induces macrophage differ-
entiation in ts21-E26 transformed myeloblasts
expressing the hGM-R. (A and B) A ts21-E26
transformed myeloblast clone expressing the
hGM-R (#G3; B) and a control clone (#C2; A)
were seeded at 428C into differentiation medium
only (closed circles), or medium supplemented
with either cMGF (open circles) or hGM-CSF
(open squares). Cell numbers were determined
daily and cumulative cell numbers calculated.
(C) After 4 d at 428C, aliquots of the cells grown
in either cMGF or hGM-CSF were cytocentri-
fuged onto slides, stained with histological dyes,
and then photographed using a CCD camera.
The big, vacuolated cells with eccentric, some-
times fragmented nuclei are mature macro-
phages.
Figure 3. Differentiation of normal
erythroid progenitors expressing exog-
enous hGM-R. (A) Three primary
erythroblast clones expressing either
the hGM-R or empty vector (control
erythroblasts) were seeded into Epotest
medium containing insulin only (con-
trol), anemic serum plus insulin (AS/Ins),
anemic serum plus insulin and hGM-
CSF (AS/Ins/GM-CSF), or hGM-CSF
and insulin (GM-CSF/Ins). At day 3 of
the experiment, hemoglobin was deter-
mined in aliquots of the cultures (Ko-
wenz et al., 1987) and plotted after nor-
malization to cell numbers. (B) 3 d after
differentiation induction cytospins were
prepared and stained with neutral ben-
zidine plus histological dyes. Images
were taken using a blue filter (480 nm)
to reveal hemoglobin by dark staining
(Beug et al., 1982). Shown are respec-
tive pictures from cultures grown in
AS/Ins and AS/Ins/GM-CSF for one
hGM-R expressing clone (#G5) as well
as one control clone (#G7). Note that
cells expressing the hGM-R fail to ac-
cumulate hemoglobin and undergo
abortive differentiation in AS/Ins, i.e.,
in the absence of hGM-CSF.The Journal of Cell Biology, Volume 141, 1998 1046
heterodimer could also be induced by one of the two
chains alone. For this, retroviral vectors were constructed
which either expressed the a chain or the bc chain of the
hGM-R (see Fig. 4 A for schematic drawings).
Erythroblast clones infected with these constructs were
generated and expression of the hGM-R proteins verified
(data not shown). Well-expressing clones were then in-
duced to differentiate in the presence of AS plus insulin or
insulin alone and analyzed for erythroid differentiation pa-
rameters as above. Erythroblasts expressing the bc chain
behaved exactly as clones containing empty vector. In the
presence of AS/insulin they expressed the same, high lev-
els of hemoglobin (Fig. 4 B) and differentiated erythro-
cytes were visible in the stained cytospins (data not shown).
In insulin alone, both cell types showed the expected abor-
tive differentiation (see above; Fig. 3 B), characterized by
much lower hemoglobin levels.
In contrast, the a chain of the hGM-R heavily interfered
with erythroid differentiation. In both insulin alone and
AS plus insulin, these erythroblasts accumulated only
heavily reduced hemoglobin levels (Fig. 4 B) and failed to
differentiate into mature erythrocytes, giving rise to mal-
formed, partially mature cells instead (abortive differenti-
ation; data not shown).
To test whether this suppression of AS-induced differ-
entiation was specific for the hGM-R a chain, we also gen-
erated clones expressing the a chain of a related cytokine
receptor, the hIL-3R (see Fig. 4 A). Surprisingly, the hIL-3R
a chain did not affect the responsiveness of erythroblasts
to AS/insulin. Rather, the hIL-3R a chain expressing clones
differentiated normally into mature erythrocytes express-
ing high hemoglobin levels (Fig. 4 B; data not shown).
These data clearly demonstrate that the a chain of the
hGM-R specifically interferes with erythroid differentia-
tion. Neither bc nor the related hIL-3R a chain could sub-
stitute for the hGM-R a chain in causing this effect. Thus,
at least part of the lineage-specific effects of the GM-R are
dependent on the a chain.
Exogenous Expression of the Murine EpoR
Prevents Interference with AS-induced Differentiation 
by the Non-liganded hGM-R
The EpoR and the GM-R share several structural and
functional characteristics, suggesting that overexpression
of one receptor may interfere with signaling of the other.
Unfortunately this question could not be addressed di-
rectly, since neither Epo nor the EpoR have been cloned
in the chicken. However, aEpo shares most biochemical
properties with mammalian Epo (Kowenz et al., 1987) and
is neutralized by a polyclonal antibody to human Epo
(Wessely, O., E.M. Deiner, and H. Beug, unpublished ob-
servations), even though aEpo fails to bind and activate
the mammalian EpoR and vice versa (Kowenz et al., 1987;
Beug, H., unpublished results). We therefore decided to
ectopically express the murine EpoR in hGM-R–express-
ing erythroblasts. If the exogenously expressed hGM-R
would interfere with the activity of the endogenous avian
EpoR (presumably expressed at much lower levels) by
quenching signals emanating from it, exogenous expres-
sion of both the mEpoR and the hGM-R at similar levels
should neutralize this effect.
To allow simultaneous expression of three proteins (i.e.,
hGM-Ra, bc, and mEpoR) in the same cell, we used an ap-
proach described previously (Tran Quang et al., 1997). Fi-
broblasts were co-transfected with the hGM-R retrovirus
plus a replication competent retroviral vector expressing
the mEpoR (RCAS-mEpoR; Fig. 5 A) and used to infect
avian bone marrow cells. G418-resistant erythroblast clones
were isolated from methocel, expanded, and then tested
for expression of the three proteins (data not shown). Well
expressing clones were analyzed for erythroid differentia-
tion as above. 4 d after differentiation induction, aliquots
of the cultures were processed for hemoglobin determina-
tion (Fig. 5 B) and histochemical staining for hemoglobin
(Fig. 5 C). Similar to erythroblasts expressing the hGM-R
only, mEpoR/hGM-R expressing cells terminally differen-
tiated in the presence of hGM-CSF plus AS. In AS/insulin
alone, the cells expressed only low levels of hemoglobin
(Fig. 5 B) and developed into abortively differentiated, apop-
totic cells (Fig. 5 C). Interestingly, and in clear contrast to
AS, activation of the exogenous mEpoR by hEpo in the
mEpoR/hGM-R–expressing cells induced their terminal
differentiation into erythrocytes expressing high hemoglo-
bin levels. Addition of hGM-CSF plus hEpo/insulin only
slightly increased hemoglobin levels beyond those induced
by the single ligands.
Figure 4. The hGM-R a chain is sufficient to interfere with ery-
throid differentiation induced by anemic serum. (A) schematic
drawings of the retroviral vectors used to express the hGM-Ra,
bc, and the hIL3-Ra. HygR, hygromycine resistance gene; hIL-
3Ra, cDNA of the human IL-3 receptor a chain; and pOli, empty
control vector. (B) Primary erythroblast clones expressing the
hGM-R (#G5), the hGM-R a chain (#1), the bc subunit (#23), the
hIl3-R a chain (#2), or the empty vector (#15) were seeded into
Epotest medium containing either insulin (control) or anemic se-
rum plus insulin (AS/Ins). 3 d after the onset of the experiment
the hemoglobin content normalized to cell number was deter-
mined. Note that only cells expressing either the hGM-R com-
plex (#G5) or the hGM-R a chain (#1) were impaired in hemo-
globin accumulation resulting from abortive differentiation in the
presence of anemic serum and insulin.Wessely et al. GM-R in Avian Hematopoiesis 1047
These results show that the interference of the exoge-
nous hGM-R with AS-induced differentiation could be
overcome, if a mEpoR was expressed in an exogenous
fashion as well, and therefore suggest that the GM-R in-
teracts with the EpoR signaling pathway.
The Ectopic hGM-R Interferes with Signaling of the 
Endogenous aEpoR
The EpoR and the GM-R share several signal transduc-
tion pathways, for instance activation of the Ras/MapK
pathway and the Stat5 pathway (Ihle et al., 1994; Mui et al.,
1995; Wakao et al., 1995). Recently, activation of Stat5b by
AS has also been reported for avian erythroid cells (Mel-
litzer et al., 1996). Therefore we used this signaling path-
way to study the effects of exogenous hGM-R on EpoR
signaling. However, primary erythroblasts do not tolerate
complete withdrawal of growth factors before re-activa-
tion with ligand (Mellitzer et al., 1996, Wessely et al.,
1997b). We therefore expressed the hGM-R and—as a
control—empty vector in the HD3 erythroblast cell line
HD3-EpoR-E22. These cells express low levels of a bioac-
tive mEpoR (,1,000 receptors per cell; Mellitzer, G., un-
published observations) and undergo terminal differentia-
tion in response to both avian and mammalian Epo, if
exogenous (v-ErbB) and endogenous receptor tyrosine
kinases (c-ErbB, c-Kit) causing sustained proliferation of
these cells are inactivated by kinase inhibitors (PD 153.035)
and ligand withdrawal (Mellitzer et al., 1996). Further-
more, these cells show the same interference of the hGM-
R with aEpoR signaling as primary cells (data not shown).
They are thus much more suitable for biochemical analysis
of signal transduction pathways (Mellitzer et al., 1996).
HD3-EpoR-E22 cells were withdrawn from growth fac-
tors overnight and re-stimulated with hGM-CSF or hEpo.
Extracts normalized to protein content were then analyzed
by phosphotyrosine blot and EMSA (see Materials and
Methods; Mellitzer et al., 1996). As a positive control,
Stat5b activation was induced in the same cells by the
c-ErbB ligand TGFa. Control HD3 cells lacking exoge-
nous hGM-R showed specific tyrosine phosphorylation of
the 80-kD EpoR after stimulation with hEpo (and of the
170-kD c-ErbB protein after TGFa stimulation), whereas
no protein was specifically phosphorylated after stimula-
tion with hGM-CSF (Fig. 6, top panel). Consequently, spe-
cific Stat5b DNA binding in EMSA assays was induced by
hEpo and TGFa but not by hGM-CSF (Fig. 6, bottom
panel). In contrast, the hGM-R–expressing HD3-EpoR
cells showed the expected, hGM-CSF-induced phosphory-
lation of the 130-kD bc protein, but surprisingly hEpo now
failed both to induce EpoR autophosphorylation and to
give rise to phosphorylated substrates. This impaired
signal transduction could be confirmed with respect to
activation of Stat5b; hGM-CSF (and TGFa) could induce
Stat5b/DNA complex formation, but hEpo could not (Fig. 6).
Taken together, these results show that exogenous over-
expression of the hGM-R actively interferes with the sig-
naling from the EpoR.
The hGM-R Cannot Replace the EpoR in Its 
Cooperation with c-Kit and Steroid Hormone Receptors 
to Induce Sustained Erythroblast Self-Renewal
The ability of the hGM-R a chain to interfere with differ-
entiation induction by the endogenous aEpoR prompted
us to study whether the hGM-R would exhibit similar
properties with respect to EpoR-dependent proliferation
control. In mouse bone marrow cultures, erythroid colo-
nies induced by Epo plus SCF are more numerous and big-
ger than those induced by Epo/Insulin, suggesting that a
cooperation of c-Kit and the EpoR causes enhanced ery-
throid progenitor proliferation (Broxmeyer et al., 1991;
McNiece et al., 1991; Muta et al., 1995). Furthermore, the
EpoR is phosphorylated by ligand-activated c-Kit in cer-
tain cell lines (Wu et al., 1995a). These findings were re-
cently extended by our finding that the EpoR cooperates
with c-Kit and steroid hormone receptors in primary
erythroid progenitors derived from chickens, humans and
Figure 5. Ectopic expression of the mEpoR can
restore Epo responsiveness in hGM-R–express-
ing erythroblasts. (A) Schematic drawings of the
two retrovirus vectors used to co-express the
hGM-R and the mEpoR (see text). (B and C)
One representative erythroblast clone simulta-
neously expressing the hGM-R and the mEpoR
(#B8) was seeded into Epotest medium contain-
ing insulin only (control), anemic serum plus in-
sulin (AS/Ins), anemic serum plus insulin and
hGM-CSF (AS/Ins/GM-CSF), hEpo plus insulin
(Epo/Ins) or hEpo plus insulin and hGM-CSF
(hEpo/Ins/GM-CSF). At day 3 of the experi-
ment, hemoglobin accumulation (normalized to
cell number) was determined (B). Simulta-
neously, aliquots of the culture were cytocentri-
fuged on slides, stained with neutral benzidine
plus histological dyes, and then photographed
under blue light (C). Dark color signifies hemo-
globin expression.The Journal of Cell Biology, Volume 141, 1998 1048
mice, causing their sustained proliferation (Wessely, O.,
E.M. Deiner, and H. Beug, unpublished observations;
Beug, H., unpublished observations; Wessely, O., and H.
Beug, unpublished observations). In the chicken system,
this was shown by the fact that expression of the mEpoR
(cooperating with c-Kit and the glucocorticoid receptor)
allowed sustained proliferation of erythroid progenitors
(see Fig. 7; Wessely, O., E.M. Deiner, and H. Beug, un-
published observations).
This system allowed us to test, if the activated hGM-R
could replace the mEpoR in its contribution to self-renewal
induction by c-Kit and steroid hormone receptors. Eryth-
roid progenitors were infected as described above with
retroviruses expressing the mEpoR or the hGM-R com-
plex. Empty vector served as a control. Cells were culti-
vated in hEpo and hGM-CSF plus the other factors re-
quired to allow sustained proliferation (see Materials and
Methods) and cell proliferation assayed by daily counting
(Fig. 7). As expected, the cells expressing the mEpoR
were capable of sustained proliferation, while control cells
lacking the mEpoR ceased to proliferate around day 6–10.
Interestingly, the cells expressing the hGM-R were com-
pletely unable to self renew. They disintegrated even
faster than the control cells.
These results clearly show, that the cooperation be-
tween EpoR and c-Kit leading to erythroblast self-renewal
is dependent on specific features of the EpoR and cannot
be substituted by a related cytokine receptor mainly active
in another hematopoietic lineage.
Discussion
In this paper we have analyzed the function of the hGM-R
in a heterologous cell system. These are primary erythroid
and myeloid progenitors of the chicken that can be in-
duced at will to either proliferate or differentiate. The
need for such experiments was obvious, since GM-CSF–
dependent immortalized cell lines like TF-1 or FDCP-mix
are extremely useful to analyze the biochemistry of GM-R
action and contribution to proliferation control, but are
less suitable to clarify how the GM-R controls the balance
between proliferation and differentiation or how it causes
lineage-specific effects. These effects of GM-CSF, how-
ever, are important in vivo. For instance, exogenously ex-
pressed GM-CSF in transgenic mice led to elevated num-
bers of macrophages, but did not cause leukemia (Elliott
et al., 1991). This suggested that one of the major tasks of
the GM-R is to control the balance between myeloid pro-
genitor proliferation and differentiation (Metcalf, 1989).
The Ligand-activated hGM-R Promotes
Myeloid Differentiation, but Does Not Contribute to 
Self-Renewal Induction
Expression of the hGM-R in ts21-E26–transformed my-
eloid progenitors was used to show that the GM-R can
have similar functions in cultured primary cells as in vivo.
These cells express a thermolabile p135gag-myb-ets oncopro-
tein and proliferate at 378C, but are induced to differentia-
tion into macrophages when shifted to 428C (Beug et al.,
1984). For both proliferation and differentiation the pres-
ence of the avian cytokine cMGF is absolutely required
(Woldmann et al., 1997). Interestingly, in hGM-R–express-
ing ts21-E26 myeloblasts hGM-CSF induced the typical
differentiation response of these progenitors i.e. termi-
nally differentiating into macrophages accompanied by a
limited number of cell divisions. However, hGM-CSF dif-
fered from cMGF in that it failed to induce long-term pro-
liferation at 378C, i.e., in the presence of a fully active
p135gag-myb-ets oncoprotein (not shown). This is in clear
Figure 6. Non-liganded GM-R inhibits signal transduction from
the EpoR. Cell extracts prepared from HD3-EpoR-E22 cells ex-
pressing the hGM-R (#G2) or, as a control, the empty vector
(#P3) were withdrawn from factors. They were then stimulated
for 15 min with TGFa, mEpo, hGM-CSF or left untreated. Ly-
sates normalized to protein content were analyzed by phosphoty-
rosine blot (top panel) as described in Materials and Methods.
Equal loading was verified by staining of the blot with Ponceau S
before antibody incubation (not shown). Open circle, phosphory-
lated, 80-kD EpoR; white arrowhead, phosphorylated 130-kD bc;
black arrow, phosphorylated, 170-kD c-ErbB protein. In addi-
tion, lysates from the same cells were analyzed by EMSA (bottom
panel), using a 32P-labeled oligonucleotide specific for Stat5b
(IFP53-GAS). Arrow indicates mobility shifted Stat5b/DNA
complex. Identity of the shifted band with Stat5b was verified by
supershift using Stat5b antibody (not shown; see Mellitzer et al.,
1996).
Figure 7. The hGM-R can-
not cooperate with c-Kit to
promote erythroblast out-
growth. Erythroid progeni-
tors expressing the hGM-R
(open squares), the mEpoR
(closed circles) or the empty
vector (closed diamonds)
were grown in CFU-E me-
dium containing hEpo,
hGM-CSF, aSCF, IGF-1,
E2, Dex, and the c-ErbB spe-
cific inhibitor PD153035 (Fry
et al., 1994) to rule out prolif-
eration stimulation by endog-
enously upregulated c-ErbB.
Cells were counted daily and
cumulative cell numbers cal-
culated.Wessely et al. GM-R in Avian Hematopoiesis 1049
contrast to GM-CSF–dependent myeloid cell lines, in
which GM-CSF is required for long-term proliferation, but
has no clear effects on differentiation. Thus, the action of
GM-CSF in suspension cultures of hGM-R–expressing
primary avian myeloid progenitors closely corresponds to
the established cytokine responses of mammalian bone
marrow in colony assays, i.e., induction of differentiation
in immature cells, stimulation of transient proliferation
during differentiation and regulation of cell function in
mature cells.
The fact that the ligand-activated hGM-R could not in-
duce long-term proliferation at 378C clearly sets GM-CSF
apart from cMGF. This is important, since the relationship
of cMGF to mammalian cytokines is still unclear. On the
sequence and structural level, cMGF is most homologous
to mammalian IL-6 with slightly less homology to G-CSF
(Sterneck et al., 1992; Boulay and Paul, 1993). On the
other hand, the in vivo activity of cMGF (i.e., a marked in-
crease of functionally activated monocytes in the periph-
eral blood of chickens constitutively expressing high levels
of cMGF) (York et al., 1996) is more easily comparable to
the biological activities of M-CSF or GM-CSF. Our result
that the ectopically expressed, ligand-activated GM-R was
unable to substitute for all activities of cMGF now rules out
the possibility that cMGF is the avian version of GM-CSF.
Function of the hGM-R in Erythroid Cells
The biological activity of GM-CSF is not restricted to the
myeloid compartment. GM-CSF also supports erythroid
differentiation (Metcalf, 1989; Nishijima et al., 1995) but in
contrast to Epo is unable to induce or maintain it on its
own. Such a BPA is also typical for other cytokines, e.g.,
IL-3. In the case of GM-CSF, it has been explained by the
loss of ligand responsiveness resulting from downregula-
tion of the GM-R during differentiation. However, ex-
tending these findings, we demonstrate here that the acti-
vated hGM-R is unable to promote terminal erythroid
differentiation even when it is exogenously expressed in
avian erythroblasts and thus cannot be downregulated.
Rather, GM-CSF must cooperate with an activity present
in anemic chicken serum. This activity is most likely Epo
since it behaves like mammalian Epo during biochemical
purification (Kowenz et al., 1987) and is neutralized by a
polyclonal antibody to mammalian Epo (Wessely, O., un-
published observations). However, formal proof of this
notion has to await molecular cloning of avian Epo and/or
its receptor.
The cooperative action of the EpoR and the GM-R
seems to be easily explainable in mechanistic terms, since
both receptors mediate signaling via the intracellular ty-
rosine kinase JAK2 (Witthuhn et al., 1993; Quelle et al.,
1994). They also activate a comparable subset of signaling
molecules like STAT5, Ras, or PI-3-kinase (Mui et al.,
1995; Pallard et al., 1995) and both receptors activate
marker genes characteristic for mature erythrocytes like
carbonic anhydrase II (CAII; Wessely, O., unpublished
observations). But why does GM-CSF only act as a BPA
even when its receptor is ectopically expressed? A possi-
ble answer to this question could be that the EpoR has
multiple activities. In addition to inducing terminal ery-
throid differentiation, the EpoR physically associates with
the tyrosine kinase receptor c-Kit and even to induce ty-
rosine phosphorylation of the latter receptor tyrosine ki-
nase (Wu et al., 1995). As shown elsewhere (Beug, H., un-
published observation; Wessely, O., E.M. Deiner, and H.
Beug, unpublished observations; Wessely, O., and H. Beug,
unpublished observations) the combination of c-Kit and
the EpoR also seem to be key players to induce long-term
proliferation in human, murine, and avian erythroblasts.
However when the hGM-R was tested in conjunction with
ligand-activated c-Kit, it failed to induce long-term out-
growth. Thus the GM-R cannot substitute for the EpoR in
its cooperation with c-Kit.
Our finding of a partial functional overlap between the
EpoR and the GM-R agree with data obtained from cy-
tokine/cytokine receptor knockout mice (Dent et al., 1990;
Dranoff and Mulligan, 1994; Robb et al., 1995; Lin et al.,
1996), showing that the various cytokine receptors exhibit
a partial functional redundancy. Ablation of these genes
usually does not lead to complete ablation of a given lin-
eage, but shows much more subtle phenotypes. Only in
case of specialized, cell type–specific receptors such as the
EpoR or the IL-5 receptor (Wu et al., 1995b; Lin et al.,
1996; Yoshida et al., 1996), the more generally expressed
cytokine receptors such as the GM-R are unable to func-
tionally substitute and thus hematopoiesis is more severely
affected.
The a Chain of the hGM-R May Confer
Myeloid Cell Specificity by Interfering with EpoR
Signal Transduction
Many functions of the GM-R are similar to those of the
IL-3 receptor. Both receptors can stimulate proliferation
of immature myeloid and erythroid progenitors, support
differentiation along these lineages, and act via similar sig-
nal transduction pathways (McNiece et al., 1991; Quelle et
al., 1992; Sonoda et al., 1994; Mui et al., 1995). This is not
surprising, since both receptors have to interact with bc
and Jak2 to initiate signal transduction. In this paper, how-
ever, we identified a biological activity specific for the
GM-R and not shared by related cytokine receptors. In
the absence of GM-CSF, the hGM-R was incompatible
with erythroid differentiation. hGM-R–expressing eryth-
roblasts disintegrated rather than differentiated in AS/Ins,
whereas hIL-3R–expressing erythroblasts differentiate nor-
mally under the same conditions (Steinlein, P., E.M. Deiner,
and H. Beug, unpublished observations). Furthermore,
isolated expression of the a or b chains of the GM-R re-
ceptor complex showed that the a chain was sufficient to
interfere with erythroid differentiation. In contrast, over-
expression of neither bc nor the IL-3R a chain exerted this
effect. These biological observations were matched by bio-
chemical data. When the hGM-R was expressed in the
erythroblast cell line HD3, hGM-CSF caused both ty-
rosine phosphorylation and DNA binding of Stat5b. How-
ever, the non-liganded hGM-R inhibited both EpoR auto-
phosphorylation and induction of Stat5b DNA binding in
response to hEpo. In HD3-EpoR control cells lacking the
exogenous hGM-R, hEpo induced both effects as ex-
pected. These results support the idea of a crucial role of
the hGM-R a chain in lineage-specific signal transduction.
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chain recently revealed that this molecule is required to-
gether with the bc chain for the activation of JAK2 (Mat-
suguchi et al., 1997). Therefore, interference by GM-R a
with signal transduction intermediates such as Jak-2 or
Stat5b in a fashion distinct from the bc chain is one possi-
ble explanation for this cross talk. Finally, experiments by
others show that overexpression of the EpoR in the mu-
rine cell line FDCP interfered specifically with signaling
from the GM-R (Quelle and Wojchowski, 1991). This cor-
responded to the finding that a protein of 100 kD could no
longer be tyrosine phosphorylated in response to hGM-
CSF, when the EpoR was exogenously expressed as well
(Quelle et al., 1992).
These results raise the interesting possibility that non-
liganded cytokine receptors may contribute to lineage
commitment by specific effects mediated via their lineage-
specific a chains. Thus, cytokine receptors may use differ-
ent mechanisms to regulate the balance between prolifera-
tion and apoptosis on the one hand and differentiation
versus proliferation/apoptosis on the other. Whereas the
former mechanism (the one easily studied in immortalized
cell lines) is always ligand dependent, the latter mecha-
nisms may be less ligand dependent, being mainly driven
by tissue-specific expression of specific types of receptor a
chains.
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